Report OverviewThe global botulinum toxin market is entering a phase of sustained expansion, with growth propelled by rising demand in both aesthetic and therapeutic domains. As a neurotoxin derived ...
An update from Sisram Medical Ltd. ( ($HK:1696) ) is now available. Sisram Medical has announced that its sublicensed botulinum toxin type A ...
Migraines affect millions in the UK, yet are often misunderstood and underestimated. From throbbing pain and nausea to ...
Beauty Clinic is opening its 11th branch in Modi’in, introducing new treatments based on trout DNA and exosomes. What exactly ...